Maria Mudryj

Title(s)Professor, MED: Medical Microbiology & Imm
SchoolSchool of Medicine
Address3147 Tupper Hall
CA 95616
Phone530-754-6090
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization. Res Sq. 2024 Aug 30. Jathal MK, Mudryj MM, Dall'Era M, Ghosh PM. PMID: 39257973; PMCID: PMC11384790.
      View in: PubMed   Mentions:
    2. Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism. Signal Transduct Target Ther. 2023 09 25; 8(1):361. Mudryj M, Ghosh PM. PMID: 37743426; PMCID: PMC10518313.
      View in: PubMed   Mentions:    Fields:    
    3. Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development. Biomedicines. 2023 Aug 07; 11(8). Katleba KD, Ghosh PM, Mudryj M. PMID: 37626712; PMCID: PMC10452427.
      View in: PubMed   Mentions: 4  
    4. Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. Int J Mol Sci. 2023 Jul 13; 24(14). Lucchesi CA, Vasilatis DM, Mantrala S, Chandrasekar T, Mudryj M, Ghosh PM. PMID: 37511154; PMCID: PMC10380322.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    5. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. J Biol Chem. 2023 08; 299(8):104973. Jathal MK, Siddiqui S, Vasilatis DM, Durbin Johnson BP, Drake C, Mooso BA, D'Abronzo LS, Batra N, Mudryj M, Ghosh PM. PMID: 37380074; PMCID: PMC10407237.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    6. Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. Sci Rep. 2023 06 14; 13(1):9617. Steele TM, Tsamouri MM, Siddiqui S, Lucchesi CA, Vasilatis D, Mooso BA, Durbin-Johnson BP, Ma AH, Hejazi N, Parikh M, Mudryj M, Pan CX, Ghosh PM. PMID: 37316561; PMCID: PMC10267166.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    7. Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Sci Rep. 2023 01 31; 13(1):1762. Katleba KD, Tsamouri MM, Jathal M, Baek HB, Armenta RB, Tepper CG, Cortopassi G, Ghosh PM, Mudryj M. PMID: 36720985; PMCID: PMC9889754.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans. Biomedicines. 2021 Oct 14; 9(10). Tsamouri MM, Steele TM, Mudryj M, Kent MS, Ghosh PM. PMID: 34680588; PMCID: PMC8533305.
      View in: PubMed   Mentions: 6  
    9. Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis. Cancer Lett. 2021 04 28; 504:49-57. Katleba K, Lombard AP, Tsamouri MM, Baek HB, Nishida KS, Libertini SJ, Platero AJ, Ma AH, Pan CX, Ghosh PM, Mudryj M. PMID: 33549708; PMCID: PMC7943249.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy. Biomedicines. 2020 Oct 15; 8(10). Messner EA, Steele TM, Tsamouri MM, Hejazi N, Gao AC, Mudryj M, Ghosh PM. PMID: 33076388; PMCID: PMC7602609.
      View in: PubMed   Mentions: 35  
    11. The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells. Cancer Lett. 2020 07 28; 483:12-21. Siddiqui S, Libertini SJ, Lucas CA, Lombard AP, Baek HB, Nakagawa RM, Nishida KS, Steele TM, Melgoza FU, Borowsky AD, Durbin-Johnson BP, Qi L, Ghosh PM, Mudryj M. PMID: 32330514; PMCID: PMC8034238.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    12. Non-circadian aspects of BHLHE40 cellular function in cancer. Genes Cancer. 2020; 11(1-2):1-19. Kiss Z, Mudryj M, Ghosh PM. PMID: 32577154; PMCID: PMC7289903.
      View in: PubMed   Mentions: 22  
    13. XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 2018 Oct 02; 9(77):34567-34581. Baek HB, Lombard AP, Libertini SJ, Fernandez-Rubio A, Vinall R, Gandour-Edwards R, Nakagawa R, Vidallo K, Nishida K, Siddiqui S, Wettersten H, Landesman Y, Weiss RH, Ghosh PM, Mudryj M. PMID: 30349650; PMCID: PMC6195388.
      View in: PubMed   Mentions: 13     Fields:    
    14. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 2017 11 16; 36(46):6359-6373. D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. PMID: 28745319; PMCID: PMC5690844.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    15. The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer. 2015 Oct; 22(5):R265-77. Lombard AP, Mudryj M. PMID: 26229034.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    16. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncol Rep. 2015 Sep; 34(3):1526-32. Lombard AP, Lim RM, Nakagawa RM, Vidallo KD, Libertini SJ, Platero AJ, Mudryj M. PMID: 26166215.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    17. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Mol Carcinog. 2016 May; 55(5):757-67. Lombard AP, Mooso BA, Libertini SJ, Lim RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM, Mudryj M. PMID: 25865490; PMCID: PMC4600638.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    18. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocr Relat Cancer. 2015 Jun; 22(3):369-86. Savoy RM, Chen L, Siddiqui S, Melgoza FU, Durbin-Johnson B, Drake C, Jathal MK, Bose S, Steele TM, Mooso BA, D'Abronzo LS, Fry WH, Carraway KL, Mudryj M, Ghosh PM. PMID: 25759396; PMCID: PMC4433410.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    19. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. PMID: 25158272; PMCID: PMC4405894.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    20. On the origins of the androgen receptor low molecular weight species. Horm Cancer. 2013 Oct; 4(5):259-69. Mudryj M, Tepper CG. PMID: 23860689; PMCID: PMC4353596.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 2012 Dec; 19(6):759-77. Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. PMID: 22993077; PMCID: PMC3540117.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    22. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells. Prostate. 2012 May 01; 72(6):649-60. Libertini SJ, Chen H, al-Bataina B, Koilvaram T, George M, Gao AC, Mudryj M. PMID: 21837779.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    23. Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block. Immunol Endocr Metab Agents Med Chem. 2011 Jun; 11(2):131-149. Jathal MK, Chen L, Mudryj M, Ghosh PM. PMID: 21603064; PMCID: PMC3095967.
      View in: PubMed   Mentions: 44  
    24. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr Relat Cancer. 2010 Dec; 17(4):857-73. Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung HJ, Ghosh PM, Mudryj M. PMID: 20634343; PMCID: PMC3539310.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    25. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J Biol Chem. 2010 Jan 22; 285(4):2368-74. Chen H, Libertini SJ, Wang Y, Kung HJ, Ghosh P, Mudryj M. PMID: 19946123; PMCID: PMC2807295.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    26. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. PMID: 19188148; PMCID: PMC2666194.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    27. Progression of prostate cancer: multiple pathways to androgen independence. Cancer Lett. 2009 Feb 18; 274(2):177-86. Devlin HL, Mudryj M. PMID: 18657355.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    28. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells. Mol Cancer Res. 2008 May; 6(5):808-18. Devlin HL, Mack PC, Burich RA, Gumerlock PH, Kung HJ, Mudryj M, deVere White RW. PMID: 18505925.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    29. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res. 2007 Oct 01; 67(19):9001-5. Libertini SJ, Tepper CG, Rodriguez V, Asmuth DM, Kung HJ, Mudryj M. PMID: 17909000.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    30. Novel p53/p130 axis in bladder tumors. Urology. 2007 Sep; 70(3):608-12. Mudryj M, Reay E, Beckett L, Dandekar S, deVere White R, Gandour-Edwards R. PMID: 17905135.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    31. E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis. Prostate. 2006 Jan 01; 66(1):70-81. Libertini SJ, Tepper CG, Guadalupe M, Lu Y, Asmuth DM, Mudryj M. PMID: 16114066.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    32. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res. 2005 Dec 01; 65(23):10700-8. Libertini SJ, Robinson BS, Dhillon NK, Glick D, George M, Dandekar S, Gregg JP, Sawai E, Mudryj M. PMID: 16322214.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    33. Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology. 2003 Jul 20; 312(1):245-53. Nguyen H, Mudryj M, Guadalupe M, Dandekar S. PMID: 12890637.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    34. Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes Immun. 2003 Jul; 4(5):336-42. Dhillon NK, Mudryj M. PMID: 12847548.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    35. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene. 2002 Jul 11; 21(30):4626-34. Dhillon NK, Mudryj M. PMID: 12096339.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    36. Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle. J Virol. 2002 Apr; 76(8):3587-95. Ndolo T, Dhillon NK, Nguyen H, Guadalupe M, Mudryj M, Dandekar S. PMID: 11907198; PMCID: PMC136077.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    37. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001 Oct 15; 20(20):5737-47. Fojas de Borja P, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M. PMID: 11598016; PMCID: PMC125670.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    38. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. Exp Cell Res. 2000 Oct 10; 260(1):9-19. Tepper CG, Seldin MF, Mudryj M. PMID: 11010806.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    39. Deregulation of specific E2F complexes by the v-mos oncogene. Oncogene. 1997 Jun 26; 14(25):3029-38. Afshari CA, Rhodes N, Paules RS, Mudryj M. PMID: 9223666.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    40. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ. 1996 Aug; 7(8):979-88. Afshari CA, Nichols MA, Xiong Y, Mudryj M. PMID: 8853893.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    41. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol. 1992 Oct; 12(10):4364-74. Wade M, Kowalik TF, Mudryj M, Huang ES, Azizkhan JC. PMID: 1328853; PMCID: PMC360360.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    42. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell. 1992 Jan 10; 68(1):167-76. Devoto SH, Mudryj M, Pines J, Hunter T, Nevins JR. PMID: 1310073.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansAnimalsCells
    43. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 1991 Jun 28; 65(7):1243-53. Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR. PMID: 1829647.
      View in: PubMed   Mentions: 130     Fields:    Translation:AnimalsCells
    44. The E2F transcription factor is a cellular target for the RB protein. Cell. 1991 Jun 14; 65(6):1053-61. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. PMID: 1828392.
      View in: PubMed   Mentions: 475     Fields:    Translation:HumansCells
    45. E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harb Symp Quant Biol. 1991; 56:157-62. Nevins JR, Chellappan SP, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T, Pines J. PMID: 1840249.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    46. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 1990 Jul; 9(7):2179-84. Mudryj M, Hiebert SW, Nevins JR. PMID: 2141565; PMCID: PMC551940.
      View in: PubMed   Mentions: 93     Fields:    Translation:AnimalsCells
    47. Deletion analysis of the mouse alpha 1(III) collagen promoter. Nucleic Acids Res. 1988 Aug 11; 16(15):7513-26. Mudryj M, de Crombrugghe B. PMID: 3412893; PMCID: PMC338424.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    48. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci U S A. 1986 10; 83(19):7137-41. Wewer UM, Liotta LA, Jaye M, Ricca GA, Drohan WN, Claysmith AP, Rao CN, Wirth P, Coligan JE, Albrechtsen R, Mudryj M, Sobel M. PMID: 2429301; PMCID: PMC386670.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    49. Transcriptional activation encoded by the v-fos gene. Proc Natl Acad Sci U S A. 1986 May; 83(10):3213-7. Setoyama C, Frunzio R, Liau G, Mudryj M, de Crombrugghe B. PMID: 3010284; PMCID: PMC323483.
      View in: PubMed   Mentions: 44     Fields:    Translation:AnimalsCells
    50. Identification of the promoter and first exon of the mouse alpha 1 (III) collagen gene. J Biol Chem. 1985 Mar 25; 260(6):3773-7. Liau G, Mudryj M, de Crombrugghe B. PMID: 3972847.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    51. Structural and functional analysis of the genes for alpha 2(I) and alpha 1(III) collagens. Ann N Y Acad Sci. 1985; 460:154-62. de Crombrugghe B, Schmidt A, Liau G, Setoyama C, Mudryj M, Yamada Y, McKeon C. PMID: 3868943.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    52. Structural and functional studies on the interstitial collagen genes. Ciba Found Symp. 1985; 114:20-33. de Crombrugghe B, Liau G, Setoyama C, Schmidt A, McKeon C, Mudryj M. PMID: 2998711.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    53. Conservation of the sizes for one but not another class of exons in two chick collagen genes. Nature. 1984 Jul 26-Aug 1; 310(5975):333-7. Yamada Y, Liau G, Mudryj M, Obici S, de Crombrugghe B. PMID: 6547770.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    54. A uniquely conserved regulatory signal is found around the translation initiation site in three different collagen genes. J Biol Chem. 1983 Dec 25; 258(24):14914-9. Yamada Y, Mudryj M, de Crombrugghe B. PMID: 6689169.
      View in: PubMed   Mentions: 30     Fields:    Translation:Cells
    55. Isolation and characterization of a genomic clone encoding chick alpha 1 type III collagen. J Biol Chem. 1983 Mar 10; 258(5):2758-61. Yamada Y, Mudryj M, Sullivan M, de Crombrugghe B. PMID: 6298201.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    56. A repetitive structure in the chick alpha 2-collagen gene. Cold Spring Harb Symp Quant Biol. 1981; 45 Pt 2:777-83. Vogeli G, Ohkubo H, Avvedimento VE, Sullivan M, Yamada Y, Mudryj M, Pastan I, de Crombrugghe B. PMID: 6942950.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    57. The collagen gene: evidence for its evolutinary assembly by amplification of a DNA segment containing an exon of 54 bp. Cell. 1980 Dec; 22(3):887-92. Yamada Y, Avvedimento VE, Mudryj M, Ohkubo H, Vogeli G, Irani M, Pastan I, de Crombrugghe B. PMID: 7460017.
      View in: PubMed   Mentions: 81     Fields:    Translation:AnimalsCells
    58. Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7059-63. Ohkubo H, Vogeli G, Mudryj M, Avvedimento VE, Sullivan M, Pastan I, de Crombrugghe B. PMID: 6452631; PMCID: PMC350440.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    59. Specificity of the bacteriophage lambda N gene product (pN): nut sequences are necessary and sufficient for antitermination by pN. Cell. 1979 Dec; 18(4):1145-51. de Crombrugghe B, Mudryj M, DiLauro R, Gottesman M. PMID: 160286.
      View in: PubMed   Mentions: 33     Fields:    Translation:Cells
    60. Nitrous acid mutagenesis of duplex DNA as a three-component system. Mutat Res. 1979 Jul; 61(2):129-51. Thomas HF, Hartman PE, Mudryj M, Brown DL. PMID: 314585.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    Maria's Networks
    Concepts (285)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California